Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Tammen

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Urology|May 7, 2002
Detection of low-molecular-mass plasma peptides in the cavernous and systemic blood of healthy men during penile flaccidity and rigidity--an experimental approach using the novel differential peptide display technologyHarald Tammen, Rüdiger Hess, Stefan Uckert, et al.
Scientific Reports|April 14, 2021
Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese miceHenrik H Hansen, Rikke V Grønlund, Tamara Baader-Pagler, et al.
Scientific Reports|January 12, 2023
Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humansHarald Tammen, Martin Kömhoff, Denis Delić, et al.
Breast Cancer Research and Treatment|June 5, 2003
Expression profiling of breast cancer cells by differential peptide displayHarald Tammen, Hans Kreipe, Rüdiger Hess, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 18, 2006
Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomasFrank Traub, Marco Jost, Rüdiger Hess, et al.
Proteomics. Clinical Applications|December 8, 2010
Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable resultsFrank Vitzthum, Gérard Siest, David M Bunk, et al.
Medical Microbiology and Immunology|January 9, 2007
Peptidomic analysis of human peripheral monocytes persistently infected by Chlamydia trachomatisBirgit Krausse-Opatz, Annette Busmann, Harald Tammen, et al.
Kidney International|April 14, 2019
Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomyAhmed A Hasan, Karoline von Websky, Christoph Reichetzeder, et al.
Biochemical Pharmacology|October 23, 2008
In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasmaMarco M Jost, Jens Lamerz, Harald Tammen, et al.
Kidney International|April 17, 2016
The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomyOleg Tsuprykov, Ryotaro Ando, Christoph Reichetzeder, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Urology|May 7, 2002
Detection of low-molecular-mass plasma peptides in the cavernous and systemic blood of healthy men during penile flaccidity and rigidity--an experimental approach using the novel differential peptide display technologyHarald Tammen, Rüdiger Hess, Stefan Uckert, et al.
Scientific Reports|April 14, 2021
Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese miceHenrik H Hansen, Rikke V Grønlund, Tamara Baader-Pagler, et al.
Scientific Reports|January 12, 2023
Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humansHarald Tammen, Martin Kömhoff, Denis Delić, et al.
Breast Cancer Research and Treatment|June 5, 2003
Expression profiling of breast cancer cells by differential peptide displayHarald Tammen, Hans Kreipe, Rüdiger Hess, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 18, 2006
Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomasFrank Traub, Marco Jost, Rüdiger Hess, et al.
Proteomics. Clinical Applications|December 8, 2010
Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable resultsFrank Vitzthum, Gérard Siest, David M Bunk, et al.
Medical Microbiology and Immunology|January 9, 2007
Peptidomic analysis of human peripheral monocytes persistently infected by Chlamydia trachomatisBirgit Krausse-Opatz, Annette Busmann, Harald Tammen, et al.
Kidney International|April 14, 2019
Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomyAhmed A Hasan, Karoline von Websky, Christoph Reichetzeder, et al.
Biochemical Pharmacology|October 23, 2008
In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasmaMarco M Jost, Jens Lamerz, Harald Tammen, et al.
Kidney International|April 17, 2016
The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomyOleg Tsuprykov, Ryotaro Ando, Christoph Reichetzeder, et al.
Pageof 4